Faes FarmaFRA:FFEA -0.11%89 Pretax Margin % is 7.57% as of Dec. 2025, which is 64% below its 10-year median of 21.27. GuruFocus rates FRA:FFEA with a GF Score™ of 89/100 and a GF Value™ of €5.10 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 956 Drug Manufacturers companies, Faes Farma ranks better than 68.2% on this metric.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Faes Farma's Pre-Tax Income for the
six
months ended in Dec. 2025 was €23.8 Mil. Faes Farma's Revenue for the
six
months ended in Dec. 2025 was €314.3 Mil. Therefore, Faes Farma's pretax margin for the quarter that ended in Dec. 2025 was 7.57%.
The historical rank and industry rank for Faes Farma's Pretax Margin % or its related term are showing as below:
FRA:FFEA'
s Pretax Margin % Range Over the Past 10 Years
Min: 13.99 Med: 21.27 Max: 23.33
Current: 13.99
FRA:FFEA's Pretax Margin % is ranked better than 68.2% of 956
companies
in the Drug Manufacturers industry
Industry Median: 7.285
vs FRA:FFEA: 13.99
Faes Farma (FRA:FFEA) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Faes Farma Pretax Margin % Related Terms
Faes Farma Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Faes Farma's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:FFEA vs ZTS, UTHR, VTRS: Pretax Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Faes Farma's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Faes Farma Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Faes Farma's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Faes Farma's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Faes Farma (FRA:FFEA) has a Pretax Margin % of 7.57% as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Faes Farma and its competitors. This is 64% below median its historical median of 21.27. Over the past decade, Faes Farma's Pretax Margin % has ranged from 13.99 to 23.33. According to the industry distribution chart, Faes Farma ranks #304 out of 956 companies in the Drug Manufacturers industry, placing it in the top 31.8%.
Is Faes Farma's Pretax Margin % too high?
Faes Farma's current Pretax Margin % of 7.57% is 64% below median its 10-year median of 21.27. Over the past 10 years, this metric has ranged from a low of 13.99 to a high of 23.33. The Drug Manufacturers industry median Pretax Margin % is 7.29. Faes Farma's value of 7.57% is 3.9% above this industry median. Based on the distribution chart, Faes Farma ranks #304 out of 956 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Faes Farma has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Faes Farma's Pretax Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Faes Farma ranks #304 out of 956 companies for Pretax Margin %. This puts Faes Farma in the upper half of its industry. The industry median Pretax Margin % is 7.29. Faes Farma's value of 7.57% is 3.9% above this benchmark. Historically, Faes Farma's own Pretax Margin % has ranged from 13.99 to 23.33 over the past decade. While the company's 10-year median is 21.27 vs. the industry median of 7.29, Faes Farma has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.29, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Faes Farma's current Pretax Margin % of 7.57% is 3.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Faes Farma and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Faes Farma's current Pretax Margin % is 7.57%, which is 64% below median its own 10-year median of 21.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Faes Farma stock overvalued right now?
Based on GuruFocus' analysis, Faes Farma (FRA:FFEA) is currently considered Modestly Undervalued. The stock's GF Value™ is €5.10, compared to a current price of €4.47 — trading 12.4% below its estimated fair value. The current Pretax Margin % is 7.57%, which is 64% below median its 10-year median of 21.27 and 3.9% above the Drug Manufacturers industry median of 7.29. Faes Farma's overall GF Score™ is 89/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Faes Farma (FRA:FFEA), the current Pretax Margin % is 7.57% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Faes Farma (FRA:FFEA) Overvalued in 2026?
Based on GuruFocus' analysis, Faes Farma stock appears to be undervalued.
The current stock price of €4.47 is trading 12.4% below its estimated GF Value™ of €5.10.
GuruFocus considers Faes Farma to be Modestly Undervalued.
Key valuation signals for FRA:FFEA:
Pretax Margin %: 7.57% (64% below median its 10-year median of 21.27)
GF Value™: €5.10 vs. price of €4.47 (12.4% below fair value)
Industry Position: 3.9% above the Drug Manufacturers median (#304 of 956)
No single metric tells the full story. See the FRA:FFEA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Faes Farma SA purpose is manufacturing and selling all kinds of chemical and pharmaceutical products, foodstuffs, cosmetics, dietetics and medicinal plants, as well as acquiring, purchasing, disposing of, investing in, holding, using, managing, administering, marketing and leasing corporations, securities and real estate, patents, trademarks and registered brands and equity interests. It is mainly engaged in the manufacture and sale of pharmaceutical products, as well as in the manufacture and sale of animal nutrition and health products. Its segments are Pharmaceutical and healthcare specialities, Animal nutrition and health, and Other segments. It generates majority of revenue from Pharmaceutical and healthcare specialities. It operates mainly in domestic and international markets.
89GF Score
Get the complete analysis for FRA:FFEA
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:FFEA has been successfully added to your 
